Mindset Pharma Correlations

Summary

MSSTFDelisted Stock

USD 0.36 0.00 0.00%

The current 90-days correlation between Mindset Pharma and Aridis Pharmaceuticals is -0.03 (i.e., Good diversification). The correlation of Mindset Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Mindset Pharma Correlation With Market

Average diversification

The correlation between Mindset Pharma and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Mindset Pharma and DJI in the same portfolio, assuming nothing else is changed.

The ability to find closely correlated positions to Mindset Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mindset Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mindset Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mindset Pharma to buy it.

Moving together with Mindset OTC Stock

0.65	NVDA	NVIDIA Aggressive Push	Pair Corr
0.79	AMZN	Amazon Inc Aggressive Push	Pair Corr
0.91	BMYMP	Bristol Myers Squibb	Pair Corr
0.64	GOOG	Alphabet Class C Aggressive Push	Pair Corr
0.83	AXP	American Express Sell-off Trend	Pair Corr
0.79	CSCO	Cisco Systems Aggressive Push	Pair Corr
0.75	T	ATT Inc Aggressive Push	Pair Corr
0.93	DIS	Walt Disney	Pair Corr
0.89	CVX	Chevron Corp Fiscal Year End 7th of February 2025	Pair Corr
0.94	BAC	Bank of America Fiscal Year End 10th of January 2025	Pair Corr
0.93	JPM	JPMorgan Chase Fiscal Year End 10th of January 2025	Pair Corr

Moving against Mindset OTC Stock

0.87	CSLLY	CSL	Pair Corr
0.86	REGN	Regeneron Pharmaceuticals	Pair Corr
0.84	CMXHF	CSL Limited	Pair Corr
0.75	NVO	Novo Nordisk AS	Pair Corr
0.73	NONOF	Novo Nordisk AS	Pair Corr
0.73	QSAM	Qsam Biosciences	Pair Corr
0.34	SGEN	Seagen Inc	Pair Corr
0.81	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.81	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.52	BA	Boeing Fiscal Year End 29th of January 2025	Pair Corr

Related Correlations Analysis

	RGIN	AXIM	BSTG	WSNAF	MCET	HESG	PMBHF	TRYPF	ARDS	FBIOP
RGIN		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	RGIN
AXIM	0.0		0.72	-0.02	0.0	0.0	-0.17	0.27	-0.5	0.46	AXIM
BSTG	0.0	0.72		0.11	0.0	0.0	0.1	0.2	-0.57	0.27	BSTG
WSNAF	0.0	-0.02	0.11		0.0	0.0	-0.04	-0.05	-0.15	-0.09	WSNAF
MCET	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	MCET
HESG	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	HESG
PMBHF	0.0	-0.17	0.1	-0.04	0.0	0.0		-0.02	-0.39	-0.46	PMBHF
TRYPF	0.0	0.27	0.2	-0.05	0.0	0.0	-0.02		-0.22	0.05	TRYPF
ARDS	0.0	-0.5	-0.57	-0.15	0.0	0.0	-0.39	-0.22		0.15	ARDS
FBIOP	0.0	0.46	0.27	-0.09	0.0	0.0	-0.46	0.05	0.15		FBIOP
	RGIN	AXIM	BSTG	WSNAF	MCET	HESG	PMBHF	TRYPF	ARDS	FBIOP

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

BSTG	+ 0.72	AXIM
FBIOP	+ 0.46	AXIM
TRYPF	+ 0.27	AXIM
FBIOP	+ 0.27	BSTG
TRYPF	+ 0.2	BSTG
FBIOP	+ 0.15	ARDS

High negative correlations

ARDS	- 0.57	BSTG
ARDS	- 0.5	AXIM
FBIOP	- 0.46	PMBHF
ARDS	- 0.39	PMBHF
ARDS	- 0.22	TRYPF
PMBHF	- 0.17	AXIM

Risk-Adjusted Indicators

There is a big difference between Mindset OTC Stock performing well and Mindset Pharma OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Mindset Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RGIN	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
AXIM	11.20	0.64	0.01	(0.15)	12.68	(37.36)	33.33	(33.33)	133.33
BSTG	1.93	(0.56)	0.00	(8.44)	0.00	0.00	4.09	(5.62)	14.60
WSNAF	26.81	6.65	0.22	3.43	21.56	(43.50)	87.88	(42.03)	178.17
MCET	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HESG	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PMBHF	4.56	0.28	0.01	11.66	6.16	(25.35)	4.17	(17.39)	108.92
TRYPF	9.23	1.14	0.06	(0.51)	10.40	(14.20)	22.17	(21.87)	75.11
ARDS	7.73	1.11	0.11	1.33	7.66	(12.31)	12.50	(12.50)	140.53
FBIOP	2.46	0.03	(0.01)	0.15	2.66	(3.10)	8.11	(4.72)	16.27

View Mindset Pharma Related Equities

Regenicin Axim Biotechnologies Biostage Wesana Health Holdings Multicell Techs Health Sciences Gr Pharmala Biotech Holdings Tryp Therapeutics Aridis Pharmaceuticals Fortress Biotech Pref Awakn Life Sciences Regenerx Biopharm In Biovaxys Technology Corp GH Research PLC Algernon Pharmaceuticals

Risk & Return

Correlation

Mindset Pharma Corporate Management

Elected by the shareholders, the Mindset Pharma's board of directors comprises two types of representatives: Mindset Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mindset. The board's role is to monitor Mindset Pharma's management team and ensure that shareholders' interests are well served. Mindset Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mindset Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.

Arvin CPA	Chief Officer	Profile
Joseph Araujo	Member Officer	Profile
Abdelmalik Slassi	VP Board	Profile
James Lanthier	Chief Officer	Profile
Jason Atkinson	VP Devel	Profile
Chris Irwin	Co Sec	Profile

Still Interested in Mindset Pharma?

Investing in delisted otcs can be risky, as the otc stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC